Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy in the General System of Noninvasive, Invasive, and Surgical Treatment of Ischemic Heart Disease in the Conditions of a Large General City Hospital (CSWTSPB40)

NCT01631409 WITHDRAWN

This study is dedicated to determination of the long term effectiveness of coronary heart disease (CHD) treatments - cardiac shock wave therapy (CSWT) in comparison with other kinds of medical and surgical treatment. For that purpose the investigators will observe the patients with CHD who enrolled in this study in their routine course of treatment. But the investigators will not interfere with the patient treatment. Each participant will be followed-up for five years. The collected data will allow to determine if the particular method, CSWT, could really make any additional contribution to the more traditional methods of CHD treatment and if the CSWT is only temporarily effective or could exert the long term effect as well.

Details

Lead sponsor	City Hospital No 40, Saint Petersburg, Russia
Status	WITHDRAWN
Start date	2013-09
Completion	2021-09

Conditions

• Coronary Heart Disease (CHD)

Interventions

• Treatment of CHD risk factors
• Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.
• Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.
• PCA
• CABG
• Cardiospec
• Aspirin, Isosorbide mononitrate, Atenolol, Enalapril

Primary outcomes

• Outcome: death — within three years after the enrolment
  the detailed circumstances and diagnose are determined by documents
• Outcome: major cardiovascular complications — within three years after the enrolment
  the detailed circumstances and diagnose are determined by documents